
TrumpRx Expansion Adds Hundreds of Generic Drugs to Federal Price Tool
Washington, DC (May 19, 2026)
The Trump administration is expanding its prescription drug pricing website with the addition of more than 600 generic medications, a major increase for the months-old federal platform aimed at helping Americans find lower-cost options for common prescriptions.
The expanded TrumpRx website is designed to give consumers a broader way to compare cash prices, identify lower-cost alternatives, and locate participating pharmacies or delivery options. The administration says the new generic drug listings will make the tool more useful for patients who are uninsured, have high deductibles, or may find that paying directly is cheaper than using their insurance coverage.
The website was launched earlier this year as part of President Donald Trump’s broader effort to reduce prescription drug costs. Its initial focus was on a smaller group of brand-name medications offered through direct-to-consumer arrangements with pharmaceutical manufacturers. The new expansion shifts the platform toward everyday prescriptions used by millions of Americans, including generic medications for chronic conditions such as diabetes, high cholesterol, and other common health needs.
Administration officials say many patients are unaware that generic versions of widely used drugs may be available at significantly lower prices than brand-name versions. By listing hundreds of generic options in one place, the White House hopes to increase price transparency and encourage consumers to ask doctors and pharmacists about more affordable alternatives.
The announcement comes as health care affordability remains a major concern for families nationwide. Prescription costs can vary widely depending on insurance status, pharmacy, manufacturer discounts, and available coupons. Officials said the site will continue adding tools intended to help patients compare prices and find the lowest available option near them.
The initiative is also part of the administration’s larger drug pricing agenda, which includes efforts to tie certain U.S. prices more closely to those paid in other developed countries. Supporters say the expansion could help patients make better-informed choices, while health policy analysts caution that savings may vary depending on the medication, insurance plan, and pharmacy access.
For consumers struggling with rising costs, the expanded platform represents another potential way to search for savings before filling a prescription.
Americans went from paying the MOST anywhere in the world for medications to paying the LOWEST drug prices for anybody in any country.
All we needed was a new president. pic.twitter.com/SDVjH7z66T
— The White House (@WhiteHouse) May 18, 2026
Mark Cuban on https://t.co/NmF0njNWnZ: "As our volumes go up, our costs go down, which means we'll be ending up charging less to people over a period of time… This is a special partnership. 559 of those drugs are ours, so we're really excited to be part of this." pic.twitter.com/VSnxBYtEPd
— Breaking911 (@Breaking911) May 18, 2026